The Current Ratio as of November 2024 (TTM) for RespireRx Pharmaceuticals Inc. (RSPI) is 0.01

According to RespireRx Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.01. This represents a change of 18.83% compared to the average of 0.01 of the last 4 quarters.

RespireRx Pharmaceuticals Inc. (RSPI) Historical Current Ratio (quarterly & annually)

How has RSPI Current Ratio performed in the past?

The mean historical Current Ratio of RespireRx Pharmaceuticals Inc. over the last ten years is 0.03. The current 0.01 Current Ratio has changed 2.93% with respect to the historical average. Over the past ten years (40 quarters), RSPI's Current Ratio was at its highest in in the September 2015 quarter at 0.17. The Current Ratio was at its lowest in in the December 2022 quarter at 0.00.

RespireRx Pharmaceuticals Inc. (RSPI) Current Ratio by Quarter and Year

Discovering the peaks and valleys of RespireRx Pharmaceuticals Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

RespireRx Pharmaceuticals Inc. (RSPI) Average Current Ratio

How has RSPI Current Ratio performed in the past?

The current Current Ratio of RespireRx Pharmaceuticals Inc. (RSPI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

RespireRx Pharmaceuticals Inc. (RSPI) Current Ratio vs. Peers

How is RSPI’s Current Ratio compared to its peers?

RespireRx Pharmaceuticals Inc.’s Current Ratio is less than Nascent Biotech, Inc. (0), less than ProtoKinetix, Incorporated (0.31), less than Silo Pharma, Inc. (0.06), less than VG Life Sciences Inc. (5.84), greater than Oxford Cannabinoid Technologies Holdings Plc (0), less than Neurobiological Technologies, Inc. (3.32), less than Pharming Group N.V. (0), less than Kane Biotech Inc. (3.53), less than Health Sciences Group, Inc. (0.82), less than Protagenic Therapeutics, Inc. (0), less than Sino Biopharmaceutical Limited (2.03), less than ZIVO Bioscience, Inc. (1.15), less than Cyteir Therapeutics, Inc. (0.17), less than Eledon Pharmaceuticals, Inc. (21.89), less than null (14.48),

Build a custom stock screener for RespireRx Pharmaceuticals Inc. (RSPI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RespireRx Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

RespireRx Pharmaceuticals Inc. (RSPI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like RespireRx Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.